促进T细胞浸润肿瘤微环境可克服对PD-L1阻断的耐药性。 - Suppr

Suppr

超能文献

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.

作者信息

Tang Haidong, Wang Yang, Chlewicki Lukasz K, Zhang Yuan, Guo Jingya, Liang Wei, Wang Jieyi, Wang Xiaoxiao, Fu Yang-Xin

出版信息

Cancer Cell. 2016 Sep 12;30(3):500. doi: 10.1016/j.ccell.2016.08.011.

DOI:10.1016/j.ccell.2016.08.011

PMID:27622338

Abstract

摘要

相似文献

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.促进T细胞浸润肿瘤微环境可克服对PD-L1阻断的耐药性。

Cancer Cell. 2016 Sep 12;30(3):500. doi: 10.1016/j.ccell.2016.08.011.

Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model.在小鼠原位胰腺肿瘤模型中，CD40激动剂抗体对肿瘤微环境的重塑与对PD-L1阻断治疗反应的改善相关。

Oncotarget. 2016 Apr 5;7(14):18508-20. doi: 10.18632/oncotarget.7610.

Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment.癌症治疗中对PD-1/PD-L1阻断的原发性和获得性耐药

Int Immunopharmacol. 2017 May;46:210-219. doi: 10.1016/j.intimp.2017.03.015. Epub 2017 Mar 18.

Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas.程序性细胞死亡配体1（PD-L1）表达并非尤因肉瘤的主要特征。

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26719. Epub 2017 Sep 4.

Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment.高级别浸润性人类口腔鳞状细胞癌微环境中程序性死亡配体1（PD-L1）表达的调控

Int J Oncol. 2017 Jan;50(1):41-48. doi: 10.3892/ijo.2016.3785. Epub 2016 Dec 2.

PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor.程序性死亡蛋白 1（PD-1）阻断增强射频消融引发的针对肿瘤的适应性免疫反应。

Clin Cancer Res. 2016 Mar 1;22(5):1173-1184. doi: 10.1158/1078-0432.CCR-15-1352.

Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma.抗血管生成治疗耐药与转移性肾细胞癌免疫抑制性肿瘤微环境相关。

Cancer Immunol Res. 2015 Sep;3(9):1017-29. doi: 10.1158/2326-6066.CIR-14-0244. Epub 2015 May 26.

IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model.白细胞介素-6和程序性死亡配体-1阻断联合治疗可抑制小鼠模型中肝细胞癌的发展。

Biochem Biophys Res Commun. 2017 Apr 29;486(2):239-244. doi: 10.1016/j.bbrc.2017.02.128. Epub 2017 Mar 1.

Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma.肿瘤周围中性粒细胞通过PD-L1/PD-1信号通路对肝细胞癌的适应性免疫产生负向调节作用。

J Exp Clin Cancer Res. 2015 Nov 18;34:141. doi: 10.1186/s13046-015-0256-0.

Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells.免疫细胞和肿瘤细胞程序性死亡配体1（B7-H1）的功能表达

Front Immunol. 2017 Aug 10;8:961. doi: 10.3389/fimmu.2017.00961. eCollection 2017.

引用本文的文献

Simultaneous STING and lymphotoxin-β receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity.同时激活STING和淋巴毒素-β受体可诱导三级淋巴结构中的B细胞反应，以增强抗肿瘤免疫力。

Nat Immunol. 2025 Sep 2. doi: 10.1038/s41590-025-02259-8.

Reduction of lymphotoxin beta receptor induces cellular senescence via the MDMX-p53 pathway.淋巴毒素β受体的减少通过MDMX-p53途径诱导细胞衰老。

Cell Death Discov. 2025 Aug 29;11(1):416. doi: 10.1038/s41420-025-02708-1.

Retrospective study on the correlation between CXCL13, immune infiltration, and tertiary lymphoid structures in cutaneous squamous cell carcinoma.皮肤鳞状细胞癌中CXCL13、免疫浸润与三级淋巴结构之间相关性的回顾性研究

PeerJ. 2025 May 7;13:e19398. doi: 10.7717/peerj.19398. eCollection 2025.

Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity.阿昔替尼与程序性死亡受体配体1（PD-L1）小干扰RNA（siRNA）共递送，以实现血管正常化与免疫检查点抑制的协同作用，增强抗癌免疫力。

J Nanobiotechnology. 2025 Mar 10;23(1):194. doi: 10.1186/s12951-025-03170-y.

Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signaling.调节性T细胞通过淋巴毒素信号通路与肿瘤细胞和内皮细胞进行串扰。

Nat Commun. 2024 Dec 2;15(1):10468. doi: 10.1038/s41467-024-54874-y.

Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies.炎症性、排除性或无反应性免疫表型中的肿瘤微环境：机制与策略

Exp Hematol Oncol. 2024 Aug 6;13(1):80. doi: 10.1186/s40164-024-00543-1.

Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8T cells for systemic antitumor responses.抗 PD-1 顺式递送低亲和力 IL-12 激活肿瘤内 CD8T 细胞以产生系统性抗肿瘤反应。

Nat Commun. 2024 Jun 3;15(1):4701. doi: 10.1038/s41467-024-49034-1.

An NGS-based assay for accurate detection and quantification of immune gene expression in mouse tumor models.基于 NGS 的方法可准确检测和定量小鼠肿瘤模型中的免疫基因表达。

PLoS One. 2024 May 20;19(5):e0303171. doi: 10.1371/journal.pone.0303171. eCollection 2024.

IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype.IFN-α/β/IFN-γ/IL-15 通路鉴定出具有免疫应答表型的 GBP1 表达肿瘤。

Clin Exp Med. 2024 May 17;24(1):102. doi: 10.1007/s10238-024-01328-w.

Tertiary lymphoid structures in cancer: maturation and induction.癌症中的三级淋巴结构：成熟与诱导。

Front Immunol. 2024 Apr 16;15:1369626. doi: 10.3389/fimmu.2024.1369626. eCollection 2024.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验